Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-08

FDA Approved: VIGABATRIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approved a supplemental application for Vigabatrin from Amneal Pharmaceuticals NY LLC, enabling a generic version of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vigabatrin (Vigabatrin)

Snippet

SUPPL AP for VIGABATRIN (VIGABATRIN)